Antisense modulation of phosphoinositide-3-kinase, regulatory subunit 4, p150 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsSusan M. Freier, Kenneth W. Dobie
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of phosphoinositide-3-kinase, regulatory subunit 4, p150. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding phosphoinositide-3-kinase, regulatory subunit 4, p150. Methods of using these compounds for modulation of phosphoinositide-3-kinase, regulatory subunit 4, p150 expression and for treatment of diseases associated with expression of phosphoinositide-3-kinase, regulatory subunit 4, p150 are provided.
Claims20
A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding phosphoinositide-3-kinase, regulatory subunit 4, p150, wherein said compound specifically hybridizes with said nucleic acid molecule encoding phosphoinositide-3-kinase, regulatory subunit 4, p150 and inhibits the expression of phosphoinositide-3-kinase, regulatory subunit 4, p150.
A compound 8 to 80 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of a preferred target region on a nucleic acid molecule encoding phosphoinositide-3-kinase, regulatory subunit 4, p150.
Dependencies are inferred from the claim text.